Autotelic Lab to present at COGI 2012

Autotelic Lab will be presenting data on its platform of expanded range point-of-care diagnostic devices
By: Autotelic Lab
Autotelic Lab
Autotelic Lab
Spread the Word
Listed Under



Fountain Valley - California - US


July 16, 2012 - PRLog -- Autotelic Lab, Fountain Valley, a developer of quantitative rapid tests, announced today that it will be presenting at COGI 2012― Quantitative Point-of-Care assay for FSH/LH/hCG.   To facilitate individualized treatment regimens that would reduce the cost of medication and adverse risks such as cancer and OHSS, we have developed point-of-care therapeutic drug monitoring of the gonadotropins widely used in IVF, namely FSH, LH, and hCG.  The potential of FSH device as a diagnostic tool for ovarian cancer will be discussed. Of particular interest is hCG quantitation which is useful for:
–   Detecting and monitoring pregnancy
–   Detecting and managing ectopic pregnancy
–   Determining risk for Down syndrome fetus
–   Predicting preeclampsia
–   Detecting and managing gestational trophoblastic disease
–   Managing testicular germ cell malignancies
–   Monitoring other human malignancies
hCG Point-of-Care testing is challenging because of the six logs in dynamic range needed to accommodate the expected clinical range of hCG (0 to >500,000 IU/L).  At COGI, Dr. Vuong Trieu and colleagues will be presenting data on our expanded range hCG assay which spans 2-20,000 IU/L, allowing for monitoring of both high risk and ectopic pregnancies.

1) Quantitative FSH/LH Point-Of-Care Assays. Vuong Trieu, Larn Hwang, Kouros Motamed, Falguni Trieu.  Poster presentation on Friday, July 20, 2012.
2) Quantitative hCG Point-Of-Care Assays.  Vuong Trieu, Larn Hwang, Kouros Motamed, Falguni Trieu.  Oral presentation will take place during the Free Communication session scheduled for Friday, 7/20/2012, between 16:30-18:00.  

About COGI:

The groundbreaking series of COGI Congresses provide a unique platform to discuss controversial issues in all fields of Obstetrics, Gynecology and Infertility. The ability to discuss only controversial topics with emphasis on clinical solutions in cases where no agreed-upon answers or consensus exist, provides clinicians with an insight and a take-home message that ameliorates treatment in the most difficult situations.

About Autotelic Lab:

Autotelic lab is a provider of quantitative point-of-care testing solutions including quantitative lateral flow cassettes, lateral flow reader, as well as a quantification service.  Our product lines include emergency care, women's health, cancer biomarkers, and regenerative medicine.  Our offerings are uniquely configured to accept multiple readers to satisfy all possible field conditions; from highly specialized requiring specificity and sensitivity to low tech without access to normal laboratory resources.  Our mission is to put testing into the hands of primary care providers and patients.   These tests are simple to use and require no specialized equipment or trained personnel.  They are rapid with results within 20 minutes of blood collection.  They are convenient and can be deployed at home, in doctor’s office, in emergency rooms, or in centralized laboratories. Moreover, they are quantitative with a linear response range superior to tests performed at centralized laboratories.  

These proprietary diagnostic devices deployed at point-of-care are being used for therapeutic drug monitoring by our partner―Biomiga Diagnostics― to personalize dosing of wide range of therapeutics e.g., chemotherapy and follicle hormone therapy (  

The executives of Autotelic Lab are a group of pharmaceutical veterans who believe that the next revolution in medicine is in point-of-care tests for optimal drug dosing.  With more than a decade of drug development experience, the leadership team has expertise ranging from basic/applied research, preclinical/clinical development, pharmacokinetics/pharmacodynamics biomarker development, mobile technology, regulatory, legal, marketing and business development.

Kouros Motamed, Ph.D.
Chief Executive Officer
Email:*** Email Verified
Tags:Hcg, Fsh, lh, Quantitation, Pregnancy, Cancer
Industry:Health, Medical
Location:Fountain Valley - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Biomiga Diagnostics PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share